Xvivo Perfusion AB (publ) (STO:XVIVO)

Xvivo Perfusion AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,801	15,403	10,379	5,459	8,215	9,018
Market Cap Growth	48.41%	48.41%	90.12%	-33.55%	-8.90%	99.42%
Enterprise Value	8,419	14,978	9,810	5,150	7,936	8,417
Last Close Price	279.40	489.00	329.50	183.00	278.50	314.00
PE Ratio	51.36	89.46	113.04	296.26	1007.78	-
Forward PE	61.68	92.61	199.34	111.93	211.39	288.07
PS Ratio	10.70	18.73	17.37	13.15	31.80	50.14
PB Ratio	4.08	7.14	5.34	3.82	6.39	8.94
P/TBV Ratio	6.17	10.81	7.84	6.86	10.06	11.59
P/FCF Ratio	216.99	379.77	3172.09	564.50	-	-
P/OCF Ratio	79.08	138.41	224.23	195.98	-	-
EV/Sales Ratio	10.24	18.21	16.42	12.40	30.71	46.80
EV/EBITDA Ratio	68.50	135.06	515.41	387.15	-	-
EV/EBIT Ratio	94.17	167.53	1818.08	1156.32	-	-
EV/FCF Ratio	207.59	369.29	2998.27	532.54	-	-
Debt / Equity Ratio	0.02	0.02	0.02	0.01	0.00	0.01
Debt / EBITDA Ratio	0.28	0.28	1.06	0.51	-	-
Debt / FCF Ratio	0.84	0.84	9.61	1.03	-	-
Asset Turnover	0.36	0.36	0.30	0.25	0.19	0.20
Inventory Turnover	1.12	1.12	1.23	1.29	1.02	0.97
Quick Ratio	3.14	3.14	4.94	2.60	4.43	5.51
Current Ratio	4.58	4.58	6.15	3.47	5.24	6.41
Return on Equity (ROE)	8.39%	8.39%	5.44%	1.36%	0.71%	-5.51%
Return on Assets (ROA)	2.43%	2.43%	0.17%	0.17%	-0.87%	-3.09%
Return on Capital (ROIC)	2.68%	2.68%	0.20%	0.20%	-1.02%	-3.45%
Return on Capital Employed (ROCE)	4.00%	4.00%	0.30%	0.30%	-	-
Earnings Yield	1.96%	1.12%	0.89%	0.34%	0.10%	-0.48%
FCF Yield	0.46%	0.26%	0.03%	0.18%	-0.27%	-0.17%
Buyback Yield / Dilution	-5.73%	-5.73%	-1.39%	-2.04%	-6.49%	-1.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.